James L. Cox

CIK: 0001665442

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ADGM

Adagio Medical Holdings, Inc.

Director

LUCD

Lucid Diagnostics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ADGM
Adagio Medical Holdings, Inc.
Jun 16, 2026
Award(A)
Non-qualified stock option (right to buy)
Direct
30K shares-
LUCD
Lucid Diagnostics Inc.
Feb 20, 2026
Award(A)
Direct
123K shares-
ADGM
Adagio Medical Holdings, Inc.
Mar 20, 2025
Award(A)
Non-qualified stock option (right to buy)
Direct
90K shares-
ADGM
Adagio Medical Holdings, Inc.
Mar 20, 2025
Award(A)
Non-qualified stock option (right to buy)
Direct
364K shares-
LUCD
Lucid Diagnostics Inc.
Feb 20, 2025
Award(A)
Direct
112.8K shares-

		Type	Shares	Price		Ownership
Jun 16, 2026	ADGM Adagio Medical Holdings, Inc.	Award(A) Non-qualified stock option (right to buy)	30,000	-	-	Direct
Feb 20, 2026	LUCD Lucid Diagnostics Inc.	Award(A)	123,000	-	$0	Direct
Mar 20, 2025	ADGM Adagio Medical Holdings, Inc.	Award(A) Non-qualified stock option (right to buy)	90,000	-	-	Direct
Mar 20, 2025	ADGM Adagio Medical Holdings, Inc.	Award(A) Non-qualified stock option (right to buy)	364,000	-	-	Direct
Feb 20, 2025	LUCD Lucid Diagnostics Inc.	Award(A)	112,800	-	-	Direct

1-5 of 5 transactions

About Cox James L

Cox James L (SEC CIK 0001665442) files insider reports with the SEC as Director of Adagio Medical Holdings, Inc. (ADGM) and Director of Lucid Diagnostics Inc. (LUCD).

Signal8 holds 4 ownership filings by Cox James L, all Form 4s, filed between Feb 21, 2025 and Aug 12, 2026. Those filings report 5 transactions, from Feb 20, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cox James L's filings is in LAGUNA HILLS, CA.

Recent filings by Cox James L

Jun 16, 2026: Grant or award of ADGM derivative securities (Form 4, code A).
Feb 20, 2026: Grant or award of LUCD shares (Form 4, code A).
Mar 20, 2025: Grants or awards of ADGM derivative securities (2 lines, Form 4, code A).
Feb 20, 2025: Grant or award of LUCD shares (Form 4, code A).

Other insiders filing for Adagio Medical Holdings, Inc. (ADGM)

Mirsaeedi-Farahani Keyvan, Director
Salmon Sean, Director
GARDINER SANDRA A., Director
MISHAN ORLY, Director
Moran Timothy P., Director
Kaster Deborah, Chief Financial Officer

How to read Form 4 transaction codes